中国上海石门一路 288 号兴 业太古汇香港兴业中心一座 26 层 邮编：200041 （86-21）5298 5488 （86-21）5298 5492 junhesh@junhe.com 关于上海健麾信息技术股份有限公司 致：上海健麾信息技术股份有限公司 君合律师事务所上海分所（以下简称"本所"）接受上海健麾信息技术股份有 限公司（以下简称"公司"）的委托，根据《中华人民共和国公司法》（以下简称 "《公司法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、《上 市公司股东会规则》（以下简称"《股东会规则》"）等法律、法规、规范性文件 （以下简称"法律、法规"）及《上海健麾信息技术股份有限公司章程》（以下简 称"《公司章程》"）的有关规定，按照律师行业公认的业务标准、道德规范和勤 勉尽责精神，就公司 2024 年年度股东大会（以下简称"本次股东大会"）有关事 宜出具本法律意见书。 为出具本法律意见书之目的，本所委派律师（以下简称"本所律师"）对公司 提供的与本次股东大会有关的文件和事实进行了核查和验证。在本所律师对公司 提供的有关文件进行核查和验证的过程中，本所假设： 提交给本所的文件都是真实、准 ...

国泰海通证券股份有限公司 关于江苏金陵体育器材股份有限公司 提前赎回金陵转债的专项核查意见 国泰海通证券股份有限公司（以下简称"保荐人"）作为江苏金陵体育器 材股份有限公司（以下简称"金陵体育"或"公司"）向不特定对象发行可转 换公司债券的保荐人，根据《证券发行上市保荐业务管理办法》《深圳证券交 易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号— —创业板上市公司规范运作》《可转换公司债券管理办法》《深圳证券交易所 上市公司自律监管指引第 15 号——可转换公司债券》等法律法规、规范性文件 的有关规定，对金陵体育提前赎回"金陵转债"的事项进行了审慎核查，具体 情况及核查意见如下： 一、可转换公司债券基本情况 （一）可转债公司债券发行情况 经中国证券监督管理委员会证监许可20203555 号文《关于同意江苏金陵体 育器材股份有限公司向不特定对象发行可转换公司债券注册的批复》核准，公司 于 2021 年 2 月 18 日公开上市 25,000.00 万元可转换公司债券，每张面值 100 元 人民币，共 250.00 万张，期限 6 年。 （二）可转债公司债券上市情况 经深圳证券交易所（以下简 ...

上海君澜律师事务所 关于 江苏金陵体育器材股份有限公司 提前赎回可转换公司债券 之 法律意见书 二〇二五年六月 上海君澜律师事务所 法律意见书 上海君澜律师事务所 关于江苏金陵体育器材股份有限公司 提前赎回可转换公司债券之 法律意见书 致：江苏金陵体育器材股份有限公司 上海君澜律师事务所（以下简称"本所"）接受江苏金陵体育器材股份有 限公司（以下简称"公司""发行人"或"金陵体育"）的委托，根据《可转 换公司债券管理办法》（以下简称"《管理办法》"）、《深圳证券交易所上 市公司自律监管指引第 15 号——可转换公司债券》（以下简称"《自律监管指 引》"）等法律、法规、规章、规范性文件及《江苏金陵体育器材股份有限公 司创业板向不特定对象发行可转换公司债券募集说明书》（以下简称"《募集 说明书》"）等规定，就金陵体育提前赎回可转换公司债券（以下简称"本次 赎回"）出具本法律意见书。 对本法律意见书，本所律师声明如下： （一）本所律师依据《中华人民共和国证券法》《律师事务所从事证券法 律业务管理办法》和《律师事务所证券法律业务执业规则（试行）》等规定及 本法律意见书出具日以前已经发生或者存在的事实，严格履行了法定职 ...

天津市依依卫生用品股份有限公司 防范控股股东、实际控制人及其他关联方资金占用管理制度 第一条 为建立天津市依依卫生用品股份有限公司（以下简称"公司"）防 范控股股东、实际控制人及其他关联方资金占用的长效机制，杜绝实际控制人、 控股股东及其他关联方资金占用行为的发生，进一步维护公司全体股东和债权人 的合法权益，根据《中华人民共和国民法典》 《中华人民共和国公司法》 《中华人 民共和国证券法》《上市公司治理准则》《深圳证券交易所股票上市规则》《上市 公司监管指引第 8 号——上市公司资金往来、对外担保的监管要求》及《天津市 依依卫生用品股份有限公司章程》 （以下简称"《公司章程》"）等规范性文件的相 关规定，并结合公司的实际情况，制定本制度。 第二条 本制度所称资金占用包括但不限于经营性资金占用和非经营性资 金占用。 经营性资金占用是指控股股东、实际控制人及其他关联方通过采购、销售等 生产经营环节的关联交易产生的资金占用； 第六条 公司不得为《股票上市规则》规定的关联法人（或其他组织）和关 联自然人提供资金等财务资助。但向关联参股公司（不包括由上市公司控股股东、 实际控制人控制的主体）提供财务资助，且该参股公司的 ...

金十图示：2025年06月25日（周三）香港恒生指数期货技术面一览（日图） | 时期 | 简单移动平均线 | 指数移动平均线 | | --- | --- | --- | | MA5 | 23791.1 | 24019.9 | | | 买入 | 买入 | | MA10 | 23833.8 | 23860.5 | | | 买入 | 买人 | | MA20 | 23738.9 | 23731.6 | | | 买入 | 买入 | | MA50 | 23044.1 | 23340.6 | | --- | --- | --- | | | 买入 | 买人 | | MA100 | 22863.5 | 22668.4 | | | 买入 | 买入 | | MA200 | 21318.0 | 21465.3 | | | 买入 | 买入 | | 买入:12 卖出:0 总结:强力买入 | | | | << | 践术指标 לל | | | 2025年06月26日 北京时间03:01 | | | | --- | --- | --- | | 名称 | 价格 | 动作 | | RSI(14) 1110. | 61.033 | 买入 | | S ...

金十数据6月26日讯，美国总统特朗普在社交媒体最新发文："为什么共和党人要让民主党"喉舌"美国之 音（VOA）继续存在？这完全是一场左翼灾难——没有共和党人应该投票支持它存续。让它消失！" 特朗普斥美国之音为民主党"喉舌" 呼吁共和党投票关停 ...

Core Insights - The National Safety Council (NSC) awarded $300,000 in grants for the 2025-2026 Research to Solutions (R2S) and MSD Solutions Pilot programs, totaling nearly $850,000 invested in musculoskeletal disorders (MSDs) prevention over three years [1][2] Group 1: Grant Programs - The grants support academic research and workplace pilot programs through the NSC MSD Solutions Lab, which was established in 2021 with funding from Amazon [2][6] - The R2S grant provides up to $50,000 for academic institutions to explore innovative MSD interventions, focusing on areas like emerging technologies and total worker wellbeing [4][5] - The MSD Solutions Pilot Grant offers $20,000 to trial safety innovations through partnerships between MSD Pledge members and technology providers [5][7] Group 2: Awardees and Projects - University of Waterloo will utilize innovative MSD risk assessment tools leveraging data from emerging technologies [7] - Auburn University plans to test a new plant-layout organizational tool for MSD control [7] - Texas Tech University will assess 3D printed head and neck rests to reduce discomfort during overhead work [7] - George Mason University aims to develop smartphone computer vision technology for real-time movement assessment to prevent MSDs in emergency responders [7] - Cargill will collaborate with MākuSafe to explore technology for risk profiling and early hazard identification [7] - Northwell will validate the benefits of a "surgeon exoskeleton" in reducing upper limb strain during complex surgical procedures [7]

Financial Data and Key Metrics Changes - The company reported significant growth in retirement assets, now exceeding $18 billion [13] - The acquisition of TradePMR has enhanced the company's capabilities in connecting financial advisors to a new generation of investors [14] - The credit card rollout has accelerated, with expectations to reach approximately 300,000 cardholders by mid-year [22][23] Business Line Data and Key Metrics Changes - The active trading platform, Legend, has seen numerous new features and improvements, including advanced charting tools and options for crypto trading [10][12] - The company has launched a prediction markets hub, with over 1.5 billion event contracts traded since its launch [12] - Robinhood strategies have managed nearly $350 million in assets for around 100,000 funded accounts [13] Market Data and Key Metrics Changes - The company has expanded its offerings in the UK and EU, including the launch of crypto staking and options trading [15] - The acquisition of Bitstamp has added an institutional business and expanded the company's global presence [15] - The company has over 500,000 funded customers outside the US [15] Company Strategy and Development Direction - The long-term vision includes becoming the number one platform for active traders, increasing wallet share, and building a global financial ecosystem [7][8] - The company aims to transition from serving only traders to addressing all financial needs of customers [13] - The focus on artificial intelligence and crypto as foundational elements of the company's future strategy [16][17] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the company's growth trajectory and the successful integration of new products and services [24][28] - The company is well-positioned to benefit from the increasing adoption of stablecoins and regulatory clarity in the market [31][34] - Management emphasized the importance of expanding into younger demographics and providing investment opportunities for children [36][38] Other Important Information - The company is preparing to launch Robinhood Banking, which will offer traditional banking services and a private banking experience for the mass market [19][20] - The company is actively working on a dividend forecasting tool, although no specific timeline was provided [41] - The company is exploring the introduction of custodial accounts for younger investors [35][38] Q&A Session Summary Question: When will Robinhood Banking launch? - Robinhood Banking is on track to launch this fall, offering traditional banking services including checks [19][20] Question: When will the credit card be rolled out to more people? - The credit card rollout has been accelerating, with expectations to reach about 300,000 cardholders by mid-year [21][23] Question: Where do we see Robinhood in five years? - The company aims to achieve significant market share in all tradable assets and expand its wallet share to include all financial assets [24][26] Question: When will Robinhood issue its own yielding stablecoin? - The company is strategically positioned to benefit from stablecoin adoption and is working with partners on USDG [31][34] Question: When will custodial accounts be available? - The company is looking to expand to younger customers and is working on initiatives to provide investment opportunities for children [35][38] Question: Does Robinhood have plans around S&P 500 inclusion? - The company believes it meets eligibility requirements but is focused on growing its business and delivering for customers [39][40] Question: When will we get a dividend forecasting tracking tool? - The company is working on this tool but does not have a specific timeline for its release [41] Question: How long before investors can invest in fixed assets like CDs and bonds? - Currently, fixed income ETFs are available, and the company is considering additional fixed income options [46][47]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of West Pharmaceutical Services, Inc. during the specified Class Period of the upcoming lead plaintiff deadline on July 7, 2025 [1] Group 1: Class Action Details - Investors who purchased West Pharmaceutical common stock between February 16, 2023, and February 12, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by July 7, 2025 [3] - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [6] Group 2: Case Allegations - The lawsuit alleges that West Pharmaceutical made false and misleading statements regarding its business operations, particularly concerning its High-Value Products portfolio and the SmartDose device [5] - Specific claims include that West was experiencing significant destocking in its high-margin products, contrary to its public statements, and that the SmartDose device was negatively impacting profit margins due to operational inefficiencies [5] - The lawsuit asserts that these misleading statements led to investor damages when the true situation was revealed [5] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4] - The firm has achieved significant settlements in the past, including the largest securities class action settlement against a Chinese company at the time, and has consistently ranked highly in terms of settlements [4] - In 2019, the firm secured over $438 million for investors, showcasing its capability in representing investor interests [4]

Group 1 - The article discusses the importance of risk management and total return investing for better portfolio decisions [1] - The author is a contributing analyst for the Sungarden Investors Club, focusing on teaching investors [1] - The article is co-authored with Rob Isbitts, the founder of the club, indicating a collaborative effort in investment education [1] Group 2 - The author has a beneficial long position in the shares of NBIS and PLTR, indicating a personal investment interest [2] - The article expresses the author's own opinions without compensation from the companies mentioned [2] - There is no business relationship with any company whose stock is mentioned, ensuring independence in analysis [2]